Biochemical and Structural Characterization of an Intramolecular Interaction in FOXO3a and Its Binding with p53

Journal of Molecular Biology

Volumn 384, Issue 3, 2008, Pages 590-603

  Wang, Feng ^a,b   Marshall, Christopher B ^a,b   Yamamoto, Kazuo ^a,b   Li, Guang Yao ^a,b   Plevin, Michael J ^a,b,c   You, Han ^a,b,d   Mak, Tak W ^a,b   Ikura, Mitsuhiko ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^d XIAMEN UNIVERSITY   (China)

Author keywords

apoptosis; FOXO3a; intramolecular interaction; NMR; p53

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR FKHRL1;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 84954358441     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.09.025     Document Type: Article

References (60)

1. Greer, E.L., Brunet, A., FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24 (2005), 7410–7425.
2. Kaestner, K.H., Knochel, W., Martinez, D.E., Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14 (2000), 142–146.
3. Arden, K.C., Biggs, W.H. 3rd., Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling. Arch. Biochem. Biophys 403 (2002), 292–298.
4. Anderson, M.J., Viars, C.S., Czekay, S., Cavenee, W.K., Arden, K.C., Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47 (1998), 187–199.
5. Accili, D., Arden, K.C., FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117 (2006), 421–426.
6. Barthel, A., Schmoll, D., Unterman, T.G., FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 16 (2005), 183–189.
7. Birkenkamp, K.U., Coffer, P.J., Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem. Soc. Trans. 31 (2003), 292–297.
8. Lynch, R.L., Konicek, B.W., McNulty, A.M., Hanna, K.R., Lewis, J.E., Neubauer, B.L., Graff, J.R., The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation. Mol. Cancer Res. 3 (2005), 163–169.
9. Tran, H., Brunet, A., Grenier, J.M., Datta, S.R., Fornace, A.J. Jr, DiStefano, P.S., et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296 (2002), 530–534.
10. Yang, L., Xie, S., Jamaluddin, M.S., Altuwaijri, S., Ni, J., Kim, E., et al. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. J. Biol. Chem. 280 (2005), 33558–33565.
11. You, H., Pellegrini, M., Tsuchihara, K., Yamamoto, K., Hacker, G., Erlacher, M., et al. FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J. Exp. Med. 203 (2006), 1657–1663.
12. Nemoto, S., Fergusson, M.M., Finkel, T., Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306 (2005), 2105–2108.
13. You, H., Yamamoto, K., Mak, T.W., Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc. Natl Acad. Sci. USA 103 (2006), 9051–9056.
14. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., Moll, U.M., p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11 (2003), 577–590.
15. Wang, X., The expanding role of mitochondria in apoptosis. Genes Dev. 15 (2001), 2922–2933.
16. Chipuk, J.E., Kuwana, T., Bouchier-Hayes, L., Droin, N.M., Newmeyer, D.D., Schuler, M., Green, D.R., Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303 (2004), 1010–1014.
17. Chipuk, J.E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D.D., Green, D.R., PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309 (2005), 1732–1735.
18. Zou, H., Li, Y., Liu, X., Wang, X., An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274 (1999), 11549–11556.
19. Slee, E.A., Harte, M.T., Kluck, R.M., Wolf, B.B., Casiano, C.A., Newmeyer, D.D., et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144 (1999), 281–292.
20. Clark, K.L., Halay, E.D., Lai, E., Burley, S.K., Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364 (1993), 412–420.
21. Tsai, K.L., Sun, Y.J., Huang, C.Y., Yang, J.Y., Hung, M.C., Hsiao, C.D., Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Res. 35 (2007), 6984–6994.
22. Boura, E., Silhan, J., Herman, P., Vecer, J., Sulc, M., Teisinger, J., et al. Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding. J. Biol. Chem. 282 (2007), 8265–8275.
23. So, C.W., Cleary, A.L., MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol. Cell. Biol. 22 (2002), 6542–6552.
24. So, C.W., Cleary, M.L., Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood 101 (2003), 633–639.
25. Chène, P., The role of tetramerization in p53 function. Oncogene 20 (2001), 2611–2617 Review.
26. 15N-enriched proteins. J. Biomol. NMR 3 (1993), 185–204.
27. Wishart, D.S., Sykes, B.D., Richards, F.M., Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol. 222 (1991), 311–333.
28. Weigelt, J., Climent, I., Dahlman-Wright, K., Wikström, M., Solution structure of the DNA binding domain of the human forkhead transcription factor AFX (FOXO4). Biochemistry 40 (2001), 5861–5869.
29. Dyson, H.J., Wright, P.E., Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6 (2005), 197–208 Review.
30. Bryson, K., McGuffin, L.J., Marsden, R.L., Ward, J.J., Sodhi, J.S., Jones, D.T., Protein structure prediction servers at University College London. Nucleic Acids Res. 33 (2005), W36–W38 Web server issue.
31. Hofseth, L.J., Hussain, S.P., Harris, C.C., p53: 25 years after its discovery. Trends Pharmacol. Sci. 25 (2004), 177–181 Review.
32. Joerger, A.C., Fersht, A.R., Structure–function–rescue: the diverse nature of common p53 cancer mutants. Oncogene 26 (2007), 2226–2242 Review.
33. Cully, M., You, H., Levine, A.J., Mak, T.W., Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6 (2006), 184–192 Review.
34. Sugase, K., Dyson, H.J., Wright, P.E., Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 447 (2007), 1021–1025.
35. Cavanagh, J., Fairbrother, W.J., Palmer, A.G. 3rd, Rance, M., Skelton, N., Protein NMR Spectroscopy: Principles and Practice. 2nd edit, 2007.
36. Stommel, J.M., Marchenko, N.D., Jimenez, G.S., Moll, U.M., Hope, T.J., Wahl, G.M., A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18 (1999), 1660–1672.
37. Tidow, H., Melero, R., Mylonas, E., Freund, S.M., Grossmann, J.G., Carazo, J.M., et al. Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc. Natl Acad. Sci. USA 104 (2007), 12324–12329.
38. Gu, J., Nie, L., Wiederschain, D., Yuan, Z.M., Identification of p53 sequence elements that are required for MDM2-mediated nuclear export. Mol. Cell. Biol. 21 (2001), 8533–8546.
39. Lohrum, M.A., Woods, D.B., Ludwig, R.L., Bálint, E., Vousden, K.H., C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 21 (2001), 8521–8532.
40. Li, M., Brooks, C.L., Wu-Baer, F., Chen, D., Baer, R., Gu, W., Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302 (2003), 1972–1975.
41. Carter, S., Bischof, O., Dejean, A., Vousden, K.H., C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat. Cell Biol. 9 (2007), 428–435.
42. Nie, L., Sasaki, M., Maki, C.G., Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination. J. Biol. Chem. 282 (2007), 14616–14625.
43. Shimizu, H., Burch, L.R., Smith, A.J., Dornan, D., Wallace, M., Ball, K.L., Hupp, T.R., The conformationally flexible S9–S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo. J. Biol. Chem. 277 (2002), 28446–28458.
44. Wallace, M., Worrall, E., Pettersson, S., Hupp, T.R., Ball, K.L., Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol. Cell 23 (2006), 251–263.
45. Obata, Y., Yamamoto, K., Miyazaki, M., Shimotohno, K., Kohno, S., Matsuyama, T., Role of cyclophilin B in activation of interferon regulatory factor-3. J. Biol. Chem. 280 (2005), 18355–18360.
46. 15N NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett. 69 (1980), 185–189.
47. Wang, A.C., Lodi, P.J., Qin, J., Vuister, G.W., Gronenborn, A.M., Clore, G.M., An efficient triple-resonance experiment for proton-directed sequential backbone assignment of medium-sized proteins. J. Magn. Reson., Ser. B 105 (1994), 196–198.
48. 15N-enriched proteins. J. Biomol. NMR 3 (1993), 185–204.
49. 15N spectra of larger proteins. Heteronuclear triple-resonance 3-dimensional NMR-spectroscopy: application to calmodulin. Biochemistry 29 (1990), 4659–4667.
50. Kay, L.E., NMR methods for the study of protein structure and dynamics. Biochem. Cell Biol. 75 (1997), 1–15.
51. 13C magnetization. J. Magn. Reson., Ser. B 101 (1993), 114–119.
52. 13C-enriched proteins. J. Magn. Reson. 88 (1990), 425–431.
53. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., Bax, A., NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995), 277–293.
54. Johnson, B.A., Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol. 278 (2004), 313–352.
55. Bartels, C., Xia, T., Billeter, M., Guntert, P., Wuthrich, K., The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 6 (1995), 1–10.
56. Güntert, P., Mumenthaler, C., Wüthrich, K., Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273 (1998), 283–298.
57. Herrmann, T., Guntert, P., Wuthrich, K., Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J. Mol. Biol. 319 (2002), 209–227.
58. Cornilescu, G., Delaglio, F., Bax, A., Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13 (1999), 289–302.
59. Nederveen, A.J., Doreleijers, J.F., Vranken, W., Miller, Z., Spronk, C.A., Nabuurs, S.B., et al. RECOORD: a recalculated coordinate database of 500+ proteins from the PDB using restraints from the BioMagResBank. Proteins 59 (2005), 662–672.
60. DeLano, W.L., The PyMOL Molecular Graphics System. 2002, DeLano Scientific.